We found a high-frequent incidence of SFRP2 methylation in the tumors (83%), confirming the recent results from Suzuki et al. [37], who reported of SFRP2 methylation in 60 of 78 (77%) primary breast carcinomas. Here, SFRP2 is linked to breast carcinoma.